Search

Find exactly what you’re looking for.
Search

Service
Showing 21-37 of 37 results

Saul Ewing is a proud sponsor of the M&A East Conference held by the Philadelphia Chapter of the Association of Corporate Growth. M&A East attracts top strategic and financial dealmakers as well as leading middle market advisors and provides an environment for valuable networking. The conference...

Developers Secure $83 Million Construction Loan For 25-Story Mixed-Use Project In Downtown Hollywood Attorneys Luis Flores and Michael Denberg of Saul Ewing represented the developer in closing the transaction. “We are proud to be part of a development team that is focused on bringing new life to...

BTI and Bridge Investment Nab $83M For Downtown Hollywood Rental BY JULIA ECHIKSON BTI Partners and Bridge Investment Group secured $83 million for a rental project on the site of the former Bread Building in Downtown Hollywood, Fla. — part of a $500 million mixed-use development — the developers...

Forest Development Announces Joint Venture Partners And Closing Of $269 Million Construction Loan For 24-Story Nautilus 220 Luis Flores, Anthony Kang, and Rick Carroll of Saul Ewing LLP represented Forest Development in closing this transaction. “This transaction underlines the strength of Peter’s...

Forest Development and RPC Land $270M For Luxury Condo Near West Palm BY JULIA ECHIKSON Forest Development and Dan Kodsi’s Royal Palm Companies scored one of South Florida’s largest construction loans this year, $269 million, for a luxury condo project north of West Palm Beach, Fla. The waterfront...

Kathryn Doyle, Partner at Saul Ewing LLP, will be presenting at the NACUA Annual Meeting, June 26-29, 2022, in Pittsburgh. She will be speaking on June 28, 9:15-10:30 a.m., on the topic "You Thought You Owned It, They Might Have Stolen It, and a Medley of Inventor Kerfuffles”. Joining Kathryn will...

Washington, D.C., November 24, 2021 – Saul Ewing LLP served as counsel to Supernus Pharmaceuticals, Inc. (NASDAQ: SUPN) in the successful completion today of its previously announced $450 million acquisition of Adamas Pharmaceuticals, Inc. (NASDAQ: ADMS). The acquisition strengthens Supernus'...

For More Information
Contact us